Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter.

AstraZeneca (NASDAQ:AZN) used its presentation at the J.P. Morgan Healthcare Conference to highlight strong 2025 performance, ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

AstraZeneca PLC AZN shares rallied 4.89% to £140.38 Tuesday, on what proved to be an all-around positive trading session for ...

The pharmaceutical sector mainstay reported good news about its developmental hypertension drug. It purchased the medicine's maker, CinCor Pharma, in early 2023. Early this morning, AstraZeneca shared ...

The AstraZeneca share price has risen to all-time highs over the past 12 months. Dr James Fox wishes he had more of the ...

AstraZeneca PLC (NASDAQ:AZN) ranks among the Best Low Volatility Investments in December 2025. BofA Securities maintained its Buy rating on AstraZeneca PLC (NASDAQ:AZN) and increased its price target ...

AstraZeneca PLC ADR advanced stock charts by Barron's. View AZN historical stock data and compare to other stocks, and ...

On Monday, AstraZeneca Plc (NASDAQ: AZN) released topline data from the LATIFY Phase 3 trial of ceralasertib in combination with Imfinzi (durvalumab). The trial did not meet the primary endpoint of ...

AstraZeneca PLC (NASDAQ:AZN) is one of the Best Non-US Stocks to Buy According to Hedge Funds. On December 16, AstraZeneca PLC (NASDAQ:AZN) announced the approval of its Saphnelo by the European Union ...

Welcome to the award-winning Money Distilled newsletter. I’m John Stepek. Every week day I look at the biggest stories in markets and economics, and explain what it all means for your money.